Global Nanomedicine Market Research Report 2023

Report ID: 1898069 | Published Date: Oct 2024 | No. of Page: 90 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Nanomedicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Quantum dots
        1.2.3 Nanoparticles
        1.2.4 Nanoshells
        1.2.5 Nanotubes
        1.2.6 Nanodevices
    1.3 Market by Application
        1.3.1 Global Nanomedicine Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 oncology
        1.3.3 Infectious diseases
        1.3.4 Cardiology
        1.3.5 Orthopedics
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Nanomedicine Market Perspective (2017-2028)
    2.2 Nanomedicine Growth Trends by Region
        2.2.1 Nanomedicine Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Nanomedicine Historic Market Size by Region (2017-2022)
        2.2.3 Nanomedicine Forecasted Market Size by Region (2023-2028)
    2.3 Nanomedicine Market Dynamics
        2.3.1 Nanomedicine Industry Trends
        2.3.2 Nanomedicine Market Drivers
        2.3.3 Nanomedicine Market Challenges
        2.3.4 Nanomedicine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Nanomedicine Players by Revenue
        3.1.1 Global Top Nanomedicine Players by Revenue (2017-2022)
        3.1.2 Global Nanomedicine Revenue Market Share by Players (2017-2022)
    3.2 Global Nanomedicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Nanomedicine Revenue
    3.4 Global Nanomedicine Market Concentration Ratio
        3.4.1 Global Nanomedicine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Nanomedicine Revenue in 2021
    3.5 Nanomedicine Key Players Head office and Area Served
    3.6 Key Players Nanomedicine Product Solution and Service
    3.7 Date of Enter into Nanomedicine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Nanomedicine Breakdown Data by Type
    4.1 Global Nanomedicine Historic Market Size by Type (2017-2022)
    4.2 Global Nanomedicine Forecasted Market Size by Type (2023-2028)
5 Nanomedicine Breakdown Data by Application
    5.1 Global Nanomedicine Historic Market Size by Application (2017-2022)
    5.2 Global Nanomedicine Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Nanomedicine Market Size (2017-2028)
    6.2 North America Nanomedicine Market Size by Country (2017-2022)
    6.3 North America Nanomedicine Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Nanomedicine Market Size (2017-2028)
    7.2 Europe Nanomedicine Market Size by Country (2017-2022)
    7.3 Europe Nanomedicine Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Nanomedicine Market Size (2017-2028)
    8.2 Asia-Pacific Nanomedicine Market Size by Country (2017-2022)
    8.3 Asia-Pacific Nanomedicine Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Nanomedicine Market Size (2017-2028)
    9.2 Latin America Nanomedicine Market Size by Country (2017-2022)
    9.3 Latin America Nanomedicine Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Nanomedicine Market Size (2017-2028)
    10.2 Middle East & Africa Nanomedicine Market Size by Country (2017-2022)
    10.3 Middle East & Africa Nanomedicine Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Combimatrix
        11.1.1 Combimatrix Company Detail
        11.1.2 Combimatrix Business Overview
        11.1.3 Combimatrix Nanomedicine Introduction
        11.1.4 Combimatrix Revenue in Nanomedicine Business (2017-2022)
        11.1.5 Combimatrix Recent Development
    11.2 Ablynx
        11.2.1 Ablynx Company Detail
        11.2.2 Ablynx Business Overview
        11.2.3 Ablynx Nanomedicine Introduction
        11.2.4 Ablynx Revenue in Nanomedicine Business (2017-2022)
        11.2.5 Ablynx Recent Development
    11.3 Abraxis Bioscience
        11.3.1 Abraxis Bioscience Company Detail
        11.3.2 Abraxis Bioscience Business Overview
        11.3.3 Abraxis Bioscience Nanomedicine Introduction
        11.3.4 Abraxis Bioscience Revenue in Nanomedicine Business (2017-2022)
        11.3.5 Abraxis Bioscience Recent Development
    11.4 Celgene
        11.4.1 Celgene Company Detail
        11.4.2 Celgene Business Overview
        11.4.3 Celgene Nanomedicine Introduction
        11.4.4 Celgene Revenue in Nanomedicine Business (2017-2022)
        11.4.5 Celgene Recent Development
    11.5 Mallinckrodt
        11.5.1 Mallinckrodt Company Detail
        11.5.2 Mallinckrodt Business Overview
        11.5.3 Mallinckrodt Nanomedicine Introduction
        11.5.4 Mallinckrodt Revenue in Nanomedicine Business (2017-2022)
        11.5.5 Mallinckrodt Recent Development
    11.6 Arrowhead Research
        11.6.1 Arrowhead Research Company Detail
        11.6.2 Arrowhead Research Business Overview
        11.6.3 Arrowhead Research Nanomedicine Introduction
        11.6.4 Arrowhead Research Revenue in Nanomedicine Business (2017-2022)
        11.6.5 Arrowhead Research Recent Development
    11.7 GE Healthcare
        11.7.1 GE Healthcare Company Detail
        11.7.2 GE Healthcare Business Overview
        11.7.3 GE Healthcare Nanomedicine Introduction
        11.7.4 GE Healthcare Revenue in Nanomedicine Business (2017-2022)
        11.7.5 GE Healthcare Recent Development
    11.8 Merck
        11.8.1 Merck Company Detail
        11.8.2 Merck Business Overview
        11.8.3 Merck Nanomedicine Introduction
        11.8.4 Merck Revenue in Nanomedicine Business (2017-2022)
        11.8.5 Merck Recent Development
    11.9 Pfizer
        11.9.1 Pfizer Company Detail
        11.9.2 Pfizer Business Overview
        11.9.3 Pfizer Nanomedicine Introduction
        11.9.4 Pfizer Revenue in Nanomedicine Business (2017-2022)
        11.9.5 Pfizer Recent Development
    11.10 Nanosphere
        11.10.1 Nanosphere Company Detail
        11.10.2 Nanosphere Business Overview
        11.10.3 Nanosphere Nanomedicine Introduction
        11.10.4 Nanosphere Revenue in Nanomedicine Business (2017-2022)
        11.10.5 Nanosphere Recent Development
    11.11 Epeius Biotechnologies
        11.11.1 Epeius Biotechnologies Company Detail
        11.11.2 Epeius Biotechnologies Business Overview
        11.11.3 Epeius Biotechnologies Nanomedicine Introduction
        11.11.4 Epeius Biotechnologies Revenue in Nanomedicine Business (2017-2022)
        11.11.5 Epeius Biotechnologies Recent Development
    11.12 Cytimmune Sciences
        11.12.1 Cytimmune Sciences Company Detail
        11.12.2 Cytimmune Sciences Business Overview
        11.12.3 Cytimmune Sciences Nanomedicine Introduction
        11.12.4 Cytimmune Sciences Revenue in Nanomedicine Business (2017-2022)
        11.12.5 Cytimmune Sciences Recent Development
    11.13 Nanospectra Biosciences
        11.13.1 Nanospectra Biosciences Company Detail
        11.13.2 Nanospectra Biosciences Business Overview
        11.13.3 Nanospectra Biosciences Nanomedicine Introduction
        11.13.4 Nanospectra Biosciences Revenue in Nanomedicine Business (2017-2022)
        11.13.5 Nanospectra Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Nanomedicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Quantum dots
    Table 3. Key Players of Nanoparticles
    Table 4. Key Players of Nanoshells
    Table 5. Key Players of Nanotubes
    Table 6. Key Players of Nanodevices
    Table 7. Global Nanomedicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Nanomedicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Nanomedicine Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Nanomedicine Market Share by Region (2017-2022)
    Table 11. Global Nanomedicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Nanomedicine Market Share by Region (2023-2028)
    Table 13. Nanomedicine Market Trends
    Table 14. Nanomedicine Market Drivers
    Table 15. Nanomedicine Market Challenges
    Table 16. Nanomedicine Market Restraints
    Table 17. Global Nanomedicine Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Nanomedicine Market Share by Players (2017-2022)
    Table 19. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2021)
    Table 20. Ranking of Global Top Nanomedicine Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Nanomedicine Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Nanomedicine Product Solution and Service
    Table 24. Date of Enter into Nanomedicine Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Nanomedicine Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Nanomedicine Revenue Market Share by Type (2017-2022)
    Table 28. Global Nanomedicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Nanomedicine Revenue Market Share by Type (2023-2028)
    Table 30. Global Nanomedicine Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Nanomedicine Revenue Market Share by Application (2017-2022)
    Table 32. Global Nanomedicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Nanomedicine Revenue Market Share by Application (2023-2028)
    Table 34. North America Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Nanomedicine Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Nanomedicine Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Nanomedicine Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Nanomedicine Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Combimatrix Company Detail
    Table 45. Combimatrix Business Overview
    Table 46. Combimatrix Nanomedicine Product
    Table 47. Combimatrix Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 48. Combimatrix Recent Development
    Table 49. Ablynx Company Detail
    Table 50. Ablynx Business Overview
    Table 51. Ablynx Nanomedicine Product
    Table 52. Ablynx Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 53. Ablynx Recent Development
    Table 54. Abraxis Bioscience Company Detail
    Table 55. Abraxis Bioscience Business Overview
    Table 56. Abraxis Bioscience Nanomedicine Product
    Table 57. Abraxis Bioscience Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 58. Abraxis Bioscience Recent Development
    Table 59. Celgene Company Detail
    Table 60. Celgene Business Overview
    Table 61. Celgene Nanomedicine Product
    Table 62. Celgene Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 63. Celgene Recent Development
    Table 64. Mallinckrodt Company Detail
    Table 65. Mallinckrodt Business Overview
    Table 66. Mallinckrodt Nanomedicine Product
    Table 67. Mallinckrodt Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 68. Mallinckrodt Recent Development
    Table 69. Arrowhead Research Company Detail
    Table 70. Arrowhead Research Business Overview
    Table 71. Arrowhead Research Nanomedicine Product
    Table 72. Arrowhead Research Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 73. Arrowhead Research Recent Development
    Table 74. GE Healthcare Company Detail
    Table 75. GE Healthcare Business Overview
    Table 76. GE Healthcare Nanomedicine Product
    Table 77. GE Healthcare Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 78. GE Healthcare Recent Development
    Table 79. Merck Company Detail
    Table 80. Merck Business Overview
    Table 81. Merck Nanomedicine Product
    Table 82. Merck Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 83. Merck Recent Development
    Table 84. Pfizer Company Detail
    Table 85. Pfizer Business Overview
    Table 86. Pfizer Nanomedicine Product
    Table 87. Pfizer Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 88. Pfizer Recent Development
    Table 89. Nanosphere Company Detail
    Table 90. Nanosphere Business Overview
    Table 91. Nanosphere Nanomedicine Product
    Table 92. Nanosphere Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 93. Nanosphere Recent Development
    Table 94. Epeius Biotechnologies Company Detail
    Table 95. Epeius Biotechnologies Business Overview
    Table 96. Epeius Biotechnologies NanomedicineProduct
    Table 97. Epeius Biotechnologies Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 98. Epeius Biotechnologies Recent Development
    Table 99. Cytimmune Sciences Company Detail
    Table 100. Cytimmune Sciences Business Overview
    Table 101. Cytimmune Sciences NanomedicineProduct
    Table 102. Cytimmune Sciences Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 103. Cytimmune Sciences Recent Development
    Table 104. Nanospectra Biosciences Company Detail
    Table 105. Nanospectra Biosciences Business Overview
    Table 106. Nanospectra Biosciences NanomedicineProduct
    Table 107. Nanospectra Biosciences Revenue in Nanomedicine Business (2017-2022) & (US$ Million)
    Table 108. Nanospectra Biosciences Recent Development
    Table 109. Research Programs/Design for This Report
    Table 110. Key Data Information from Secondary Sources
    Table 111. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Nanomedicine Market Share by Type: 2021 VS 2028
    Figure 2. Quantum dots Features
    Figure 3. Nanoparticles Features
    Figure 4. Nanoshells Features
    Figure 5. Nanotubes Features
    Figure 6. Nanodevices Features
    Figure 7. Global Nanomedicine Market Share by Application in 2021 & 2028
    Figure 8. oncology Case Studies
    Figure 9. Infectious diseases Case Studies
    Figure 10. Cardiology Case Studies
    Figure 11. Orthopedics Case Studies
    Figure 12. Others Case Studies
    Figure 13. Nanomedicine Report Years Considered
    Figure 14. Global Nanomedicine Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 15. Global Nanomedicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global Nanomedicine Market Share by Region: 2021 VS 2028
    Figure 17. Global Nanomedicine Market Share by Players in 2021
    Figure 18. Global Top Nanomedicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanomedicine as of 2021)
    Figure 19. The Top 10 and 5 Players Market Share by Nanomedicine Revenue in 2021
    Figure 20. North America Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. North America Nanomedicine Market Share by Country (2017-2028)
    Figure 22. United States Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Canada Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Europe Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Europe Nanomedicine Market Share by Country (2017-2028)
    Figure 26. Germany Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Nanomedicine Market Share by Region (2017-2028)
    Figure 34. China Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Japan Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. South Korea Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Southeast Asia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. India Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Australia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Latin America Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Latin America Nanomedicine Market Share by Country (2017-2028)
    Figure 42. Mexico Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Brazil Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Middle East & Africa Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Middle East & Africa Nanomedicine Market Share by Country (2017-2028)
    Figure 46. Turkey Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Saudi Arabia Nanomedicine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Combimatrix Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 49. Ablynx Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 50. Abraxis Bioscience Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 51. Celgene Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 52. Mallinckrodt Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 53. Arrowhead Research Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 54. GE Healthcare Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 55. Merck Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 56. Pfizer Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 57. Nanosphere Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 58. Epeius Biotechnologies Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 59. Cytimmune Sciences Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 60. Nanospectra Biosciences Revenue Growth Rate in Nanomedicine Business (2017-2022)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
Frequently Asked Questions
Nanomedicine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Nanomedicine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Nanomedicine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Natural Gas Liquids

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Neem Extract

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More